Circulating salusin-beta levels in the patients with age-related macular degeneration
Open Access
- 11 February 2021
- journal article
- Published by Heighten Science Publications Corporation in International Journal of Clinical and Experimental Ophthalmology
- Vol. 5 (1), 001-004
- https://doi.org/10.29328/journal.ijceo.1001034
Abstract
Purpose: To evaluate the levels of salusin-beta (β-SAL) in the serum in patients with age-related macular degeneration (ARMD). Methods: Our study was designed as a controlled comparative clinical study. The β-SAL levels in serums of age and sex-matched 20 healthy volunteers as controls (Group 1), 20 patients with dry-age related macular degeneration (d-ARMD) (Group 2) and 20 patients with wet-age related macular degeneration (w-ARMD) (Group 3) were measured with the enzyme-linked immunosorbent assay (ELISA) method. Results: In our study, it was found that age and gender didn’t show a statistically significant difference among the study groups (p > 0. 05). The mean serum β-SAL levels in Group 1, Group 2 and Group 3 were 1372,17 ± 1126.69 pg/mL; 1423,71 ± 1196.84 pg/mL and 940,57 ± 1092.05 pg/mL, respectively. Although the meanβ-SAL levels in w-ARMD seem numerically lower than both the control and d-ARMD groups, this difference among the study groups was not statistically significant (p > 0.05). Conclusion: Our study suggests that β-SAL levels in the patients with ARMD and healthy controls were not different than each other. Further studies with large numbers may reveal possible relationships between β-SAL and ARMD.Keywords
This publication has 35 references indexed in Scilit:
- Salusins: Potential Use as a Biomarker for Atherosclerotic Cardiovascular DiseasesInternational Journal of Hypertension, 2013
- Circulating Levels of Human salusin-β,a Potent Hemodynamic and Atherogenesis RegulatorPLOS ONE, 2013
- Age‐related macular degeneration—clinical review and genetics updateClinical Genetics, 2013
- The Role of the Immune Response in Age-Related Macular DegenerationInternational Journal of Inflammation, 2013
- Salusin-β accelerates inflammatory responses in vascular endothelial cells via NF-κB signaling in LDL receptor-deficient mice in vivo and HUVECs in vitroAmerican Journal of Physiology-Heart and Circulatory Physiology, 2012
- Complement component C5a Promotes Expression of IL-22 and IL-17 from Human T cells and its Implication in Age-related Macular DegenerationJournal of Translational Medicine, 2011
- The Effects of Th17 Cytokines on the Inflammatory Mediator Production and Barrier Function of ARPE-19 CellsPLOS ONE, 2011
- Immunopathological aspects of age-related macular degenerationSeminars in Immunopathology, 2008
- The role of complement in ocular pathologySeminars in Immunopathology, 2008
- Synthetic Salusins as Cardiac Depressors in RatHypertension, 2005